NBA Hall of Famer Ben Wallace Signs Exclusive Licensing Agreement with Michigan Cannabis Brand

1.3 min readPublished On: October 20th, 2021By

DETROIT- During his Hall of Fame career, Detroit Pistons’ legend Ben Wallace played with intensity and passion. He plans to bring the same qualities to the Michigan cannabis industry through an exclusive licensing agreement with Jackson-based Rair. As part of the agreement, Wallace will develop his own brand of cannabis products, including his own strain. Products in the early 2022 launch include cannabis flower, pre-rolls and vape cartridges, with future products to be announced.

“As a former pro athlete, I’ve got aches and pains and different stresses than before. Cannabis has helped with all that, safely,” said Wallace. “After working with the Rair team for the last couple of months, I know this will be a great partnership. They’re serious about growing quality products and ending the stigma around cannabis use, and we’re going to bring you a brand that shows the grit and toughness my teams and I always brought to the court in Detroit.”

“We are thrilled to announce our partnership with NBA legend Ben Wallace and excited to build a brand with him,” said Kevin McFadden, CEO of Rair. “Ben’s work ethic, drive and dedication to excellence aligns with Rair’s promise to provide best in class cannabis products to the patients and recreational customers of Michigan.”

Rair’s Ben Wallace brand will be released in the coming weeks, along with the logo and packaging design, both of which are being developed by Rair’s advertising agency, Atomic Honey in Detroit.

(This information is primarily sourced from Rair Cannabis.  Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).

About the Author: HCN News Team

The News Team at Highly Capitalized are some of the most experienced writers in cannabis and psychedelics business & finance. We cover capital markets, finance, branding, marketing and everything important in between. Most of all, we follow the money.

Share This Story, Choose Your Platform!